Rofo 2017; 189(07): 611-623
DOI: 10.1055/s-0043-110011
Review
© Georg Thieme Verlag KG Stuttgart · New York

White Paper: Interventional MRI: Current Status and Potential for Development Considering Economic Perspectives, Part 1: General Application

Article in several languages: English | deutsch
Jörg Barkhausen
1  Department of Radiology and Nuclear Medicine, University Hospital Schleswig Holstein Luebeck Campus, Germany
,
Thomas Kahn
2  Clinic and Policlinic for Diagnostic and Interventional Radiology, Leipzig, Germany
,
Gabriele A. Krombach
3  Department of Radiology, University Hospital Giessen, Justus Liebig University, Giessen, Germany
,
Christiane K. Kuhl
4  Department of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Germany
,
Joachim Lotz
5  Institute for Diagnostic and Interventional Radiology, Georg-August-University Goettingen, Germany
,
David Maintz
6  Department of Radiology, University Hospital of Cologne, Cologne, Germany
,
Jens Ricke
7  Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Germany
,
Stefan O. Schönberg
8  Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
,
Thomas J. Vogl
9  Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Germany
,
Frank K. Wacker
10  Department for Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany
,
German Association of Chairmen in Academic Radiology (KLR)
› Author Affiliations
Further Information

Publication History

20 October 2016

12 April 2017

Publication Date:
26 June 2017 (online)

Abstract

Background MRI is attractive for the guiding and monitoring of interventional procedures due to its high intrinsic soft tissue contrast and the possibility to measure physiologic parameters like flow and cardiac function.

Method The current status of interventional MRI for the clinical routine was analyzed.

Results The effort needed for the development of MR-safe monitoring systems and instruments initially resulted in the application of interventional MRI only for procedures that could not be performed by other means. Accordingly, biopsy of lesions in the breast, which are not detectable by other modalities, has been performed under MRI guidance for decades. Currently, biopsies of the prostate under MRI guidance are established in a similar fashion. At many sites blind biopsy has already been replaced by MR-guided biopsy or at least by the fusion of MR images with ultrasound. Cardiovascular interventions are performed at several centers for ablation as a treatment for atrial fibrillation.

Conclusion Interventional MRI has been established in the clinical routine for a variety of indications. Broader application can be expected in the clinical routine in the future owing to the multiple advantages compared to other techniques.

Key points

  • Due to the significant technical effort, MR-guided interventions are only recommended in the long term for regions in which MRI either facilitates or greatly improves the intervention.

  • Breast biopsy of otherwise undetectable target lesions has long been established in the clinical routine. Prostate biopsy is currently being introduced in the clinical routine for similar reasons. Other methods such as MR-guided focused ultrasound for the treatment of uterine fibroids or tumor ablation of metastases represent alternative methods and are offered in many places.

  • Endovascular MR-guided interventions offer advantages for a number of indications and have already been clinically established for the treatment of children with congenital heart defects and for atrial ablation at individual centers. Greater application can be expected in the future.

Citation format

  • Barkhausen J, Kahn T, Krombach GA et al. White Paper: Interventional MRI: Current Status and Potential for Development Considering Economic Perspectives, Part 1: General Application. Fortschr Röntgenstr 2017; 189: 611 – 623